A second look at bivalirudin

Am Heart J. 2001 Dec;142(6):929-31. doi: 10.1067/mhj.2001.119375.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Comment

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Antithrombins / economics
  • Antithrombins / therapeutic use*
  • Clinical Trials as Topic
  • Coronary Disease / drug therapy*
  • Cost-Benefit Analysis
  • Data Interpretation, Statistical
  • Hirudin Therapy*
  • Hirudins / analogs & derivatives*
  • Hirudins / economics
  • Humans
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / prevention & control*
  • Odds Ratio
  • Peptide Fragments / economics
  • Peptide Fragments / therapeutic use*
  • Radiography
  • Recombinant Proteins / economics
  • Recombinant Proteins / therapeutic use*
  • Recurrence
  • Research Design
  • Treatment Outcome

Substances

  • Antithrombins
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • bivalirudin